Mahesh Parmar - Concepedia

Author

Mahesh Parmar

Also Known As

A.R. Devi, B Rachet, Daar, Eric S., Delfabbro, Dr. (Prof) M. N. Parmar, Fleur Hudson, M K B Parmar, M K Parmar, M PARMAR, M Parmar

555

Publications

57.4K

Citations

103

H-Index

142

Concepts

All Affiliations

University College London MRC Clinical Trials Unit at UCL Medical Research Council Cardiff University Institute of Cancer Research

About

Mahesh Parmar is an author at University College London specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	17	19	5.1K
2	Engineering	3	3	107
3	Business	1	1	21
4	Humanities	1	1	26
5	Management	1	1	21

Mahesh Parmar

230

Publications

50.3K

Citations

H-Index

Page 1

	Year	Citations
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Mahesh Parmar, Valter Torri, Lesley Stewart Statistics in Medicine	1998	4.8K
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Hashim U. Ahmed, Ahmed El‐Shater Bosaily, Louise Brown, The Lancet	2017	3.1K
A Phase 3 Trial of Bevacizumab in Ovarian Cancer Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, New England Journal of Medicine	2011	2.1K
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, The Lancet	2015	1.9K
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy Nicholas D. James, Johann S. de Bono, Melissa Spears, New England Journal of Medicine	2017	1.7K
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial David Sebag‐Montefiore, Richard Stephens, R. Steele, The Lancet Surgical OncologyHealth SciencesRadiation TherapyMedicineRectal Cancer	2009	1.5K
Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects Patrick Royston, Mahesh Parmar Statistics in Medicine Cox ModelsPrognosisEpidemiology Of CancerTreatment EffectProportional‐odds Models	2002	1.4K
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Christopher Parker, Nicholas D. James, Chris Brawley, The Lancet	2018	1.2K
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial Mahesh Parmar, Jonathan A. Ledermann, Nicoletta Colombo, The Lancet MedicineMetronomic TherapyGynecologyConventional Platinum-based ChemotherapyRelapsed Ovarian Cancer	2003	1.2K
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial Ian Jacobs, Usha Menon, Andy Ryan, The Lancet	2015	1.1K

Page 1